Detecting and classifying copy number variation
AssigneeVerinata Health, Inc.
InventorsRichard P. Rava, Brian K. Rhees
Life of this patent
Estimating the term…
Loading patent…
AssigneeVerinata Health, Inc.
InventorsRichard P. Rava, Brian K. Rhees
Estimating the term…
The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined according to the method include trisomies and monosomies of any one or more of chromosomes 1-22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample.
A method, implemented using a computer system comprising one or more processors and system memory, of identifying at least one normalizing sequence for normalizing coverage of a sequence of interest suspected of having a copy number variation in an organism, the method comprising:
A computer program product comprising a non-transitory computer readable medium storing program code that, when executed by one or more processors of a computer system, causes the computer system to determine a normalizing sequence of a sequence of interest, said program code comprising:
A system comprising one or more processors, system memory, and one or more computer-readable storage media having stored thereon instructions for execution on said processor to:
Dependencies are inferred from the claim text.